Literature DB >> 15736218

Non-invasive tests to predict fetal anemia in Kell-alloimmunized pregnancies.

H van Dongen1, F J C M Klumper, E Sikkel, F P H A Vandenbussche, D Oepkes.   

Abstract

OBJECTIVES: To compare test characteristics of ultrasound and Doppler parameters in the prediction of fetal anemia in Kell-alloimmunized pregnancies.
METHODS: In this prospective study, 27 fetuses at risk for anemia due to Kell alloimmunization were evaluated with ultrasound and Doppler imaging. Spleen perimeter, liver length, middle cerebral artery (MCA) peak systolic velocity and intrahepatic umbilical venous (IHUV) maximum velocity were measured. Results were compared with fetal hemoglobin values at first intrauterine blood sampling or delivery. Severe fetal anemia was defined as a hemoglobin deficit of at least 5 SD below the mean for gestational age.
RESULTS: Eighteen fetuses were anemic and required intrauterine transfusions. In the other nine pregnancies no transfusions were performed; one of these fetuses was severely anemic at birth. MCA and IHUV flow velocities were the best predictors of fetal anemia in Kell alloimmunized fetuses (sensitivity 89% for each test). Sensitivities for spleen perimeter (15%) and liver length (14%) were disappointing.
CONCLUSIONS: Doppler evaluation of MCA peak systolic velocity and IHUV maximum velocity can be used to reliably predict severe fetal anemia in Kell alloimmunization. Copyright 2005 ISUOG

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736218     DOI: 10.1002/uog.1821

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  2 in total

1.  Middle cerebral artery Doppler.

Authors:  Janet Brennand
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

2.  Hydrops Fetalis due to Kell Alloimmunization: A Perinatal Approach to a Rare Case.

Authors:  Arzu Akdağ; Omer Erdeve; Nurdan Uraş; Yavuz Simşek; Uğur Dilmen
Journal:  Turk J Haematol       Date:  2012-03-05       Impact factor: 1.831

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.